Monday, 3 October 2016

Hormone therapy for prostate cancer less safe for men with prior heart attack

A new study conducted at Yale University's Department of Therapeutic Radiology indicates that hormone-depleting therapy, often prescribed to men with prostate cancer, may pose a risk for those patients who have survived a heart attack.  While the study noted that younger patients with less cardiac risk factors benefited more positively from the hormone therapy, Dr. Manish Vira, vice chair for urologic research at the Arthur Smith Institute for Urology in New Hype Park,New York, stated tat "men who had prior documented history of heart disease as demonstrated by prior heart attack were potentially harmed by the addition of hormonal therapy."

To read more about this study, presented at the September 28th meeting of the American Society for Therapeutic Radiology and Oncology, click here.

No comments:

Post a Comment